133 related articles for article (PubMed ID: 2994305)
1. Squamous carcinoma of the nasopharynx.
Moloy PJ; Chung YT; Krivitsky PB; Kim RC
West J Med; 1985 Jul; 143(1):66-9. PubMed ID: 2994305
[TBL] [Abstract][Full Text] [Related]
2. [Immunoglobulin A serum antibodies against the capsid antigen of Epstein-Barr virus in the differential diagnosis and follow-up of nasopharyngeal cancer].
Pavelka R; Popow-Kraupp T; Radaszkiewicz T
Wien Klin Wochenschr; 1985 Jul; 97(14):588-95. PubMed ID: 2996246
[TBL] [Abstract][Full Text] [Related]
3. [Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].
Caliceti U; Cevenini R; Donati M
Acta Otorhinolaryngol Ital; 1985; 5(1):83-90. PubMed ID: 2994355
[No Abstract] [Full Text] [Related]
4. A prospective evaluation of patients with nasopharyngeal carcinoma: an overview.
Neel HB
J Otolaryngol; 1986 Jun; 15(3):137-44. PubMed ID: 3014165
[TBL] [Abstract][Full Text] [Related]
5. [Neck lymph node metastases of unknown origin: nasopharyngeal origin and EBV (Epstein-Barr virus)].
Plaza G; Santón A; Fogué L; Bellas C; Martínez Vidal A
Acta Otorrinolaringol Esp; 1999; 50(8):623-9. PubMed ID: 10619898
[TBL] [Abstract][Full Text] [Related]
6. [Schmincke carcinoma of the nasopharynx (author's transl)].
von Ilberg C; Kleinmann H; Arnold W
Laryngol Rhinol Otol (Stuttg); 1976 May; 55(5):420-8. PubMed ID: 135168
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
[TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal carcinoma and Epstein-Barr virus. II. Clinical course and the anti-VCA antibody.
Lynn T; Tu S; Hirayama T; Kawamura A
Jpn J Exp Med; 1973 Apr; 43(2):135-44. PubMed ID: 4352112
[No Abstract] [Full Text] [Related]
9. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
Wilmes E; Wolf H; Deinhardt F; Naumann HH
Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):4-6. PubMed ID: 6261051
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal carcinoma. Clinical presentation, diagnosis, treatment, and prognosis.
Neel HB
Otolaryngol Clin North Am; 1985 Aug; 18(3):479-90. PubMed ID: 2995899
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
12. [Atypical involvement of undifferentiated carcinomas of the nasopharyngeal type. Apropos of 3 cases].
Le Roy A; Honigman I; Chevalier E; Hazan A; Bodiguel V; Adotti F; Peytral C
Ann Otolaryngol Chir Cervicofac; 1998 Nov; 115(5):288-92. PubMed ID: 9881177
[TBL] [Abstract][Full Text] [Related]
13. [Cancer of the nasopharynx: our experience with 34 cases].
de Miguel García F; Fraile Rodrigo JJ; Fernández Liesa R; Yus Gotor C; de Miguel Hernández D
Acta Otorrinolaringol Esp; 1989; 40(6):419-24. PubMed ID: 2631912
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic evaluation of nasopharyngeal carcinoma: role of Epstein-Barr virus].
Plaza G; Fogué L; Martínez San Millán J; Martínez Vidal A; Bellas C
An Otorrinolaringol Ibero Am; 2002; 29(1):71-91. PubMed ID: 11962004
[TBL] [Abstract][Full Text] [Related]
15. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for loco-regional control and outcome of re-irradiation for patients with poorly-differentiated squamous cell carcinoma of the nasopharynx.
Mitsuhashi N; Sakurai H; Takahashi M; Maebayashi K; Tamaki Y; Hashida I; Akimoto T; Nakamoto S; Takahashi T; Hayakawa K
Jpn J Clin Oncol; 1995 Jun; 25(3):72-8. PubMed ID: 7596051
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.
Henle W; Henle G; Ho HC; Burtin P; Cachin Y; Clifford P; de Schryver A; de-Thé G; Diehl V; Klein G
J Natl Cancer Inst; 1970 Jan; 44(1):225-31. PubMed ID: 11515035
[No Abstract] [Full Text] [Related]
18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
19. [Nasopharyngeal carcinoma in childhood].
Huang TB
Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):123-6. PubMed ID: 2401174
[TBL] [Abstract][Full Text] [Related]
20. Outcome of patients with positive Epstein-Barr virus serologic status in the absence of nasopharyngeal carcinoma in Hong Kong.
Lo S; Ho WK; Wei WI
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):770-2. PubMed ID: 15210561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
